Opal 40 mg/vial (IV Injection)
40 mg vial: ৳ 95.00
Medicine Details
Category | Details |
---|---|
Generic | Omeprazole |
Company | Healthcare pharmaceuticals ltd |
Also available as |
Indications
- Gastric and duodenal ulcer
- NSAID-associated duodenal and gastric ulcer
- Prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
- Gastro-esophageal reflux disease
- Long-term management of acid reflux disease
- Acid-related dyspepsia
- Severe ulcerating reflux esophagitis
- Prophylaxis of acid aspiration during general anesthesia
- Zollinger-Ellison syndrome
- Helicobacter pylori-induced peptic ulcer
Pharmacology
- Inhibitor of gastric acid secretion
- Blocks hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system
- Onset of antisecretory effect within one hour
- Maximum effect within two hours
- Inhibition of secretion lasts up to 72 hours
- Return of secretory activity gradually over 3 to 5 days after discontinuation
Dosage
- Dosage for various conditions specified
Administration
- Oral administration instructions
- IV injection administration instructions
- IV infusion administration instructions
Interaction
- Reduced absorption of ketoconazole during Opal treatment
- Metabolized in the liver through cytochrome P450
- Possible delay in elimination of diazepam, phenytoin, and warfarin
- Increased plasma concentrations of Opal and clarithromycin during concomitant administration
Contraindications
- Known hypersensitivity to omeprazole
- Exclusion of malignancy before treatment initiation if gastric ulcer is suspected
Side Effects
- Mild and reversible adverse reactions
- Skin rash, urticaria, and pruritus
- Photosensitivity, bullous eruption, and erythema multiforme
- Diarrhea, headache, constipation, nausea/vomiting, flatulence, and abdominal pain
- Dry mouth, stomatitis, and candidiasis
- Paraesthesia, dizziness, light headedness, and feeling faint
- Somnolence, insomnia, and vertigo
- Reversible mental confusion, agitation, depression, and hallucinations
- Arthritic and myalgic symptoms
- Various other isolated reported effects
Pregnancy & Lactation
- No adverse effects on pregnancy or fetus/newborn child based on prospective studies
- Use during pregnancy considered safe
- No information on passage into breast milk or effects on the neonate
- Discontinuation of breastfeeding if Omeprazole use is essential
Precautions & Warnings
- Avoid concomitant use with clopidogrel
- Possible association with increased risk for osteoporosis-related fractures
- Atrophic gastritis noted occasionally in long-term treated patients
- Potential for methotrexate toxicities when used concomitantly
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Related Brands
- Opal 40 mg (Capsule (Enteric Coated)) - healthcare-pharmaceuticals-ltd
- Opal 20 mg (Capsule (Enteric Coated)) - healthcare-pharmaceuticals-ltd
- OP-40 40 mg/vial (IV Injection) - globe-pharmaceuticals-ltd
- OP-40 40 mg (Capsule (Enteric Coated)) - globe-pharmaceuticals-ltd
- OP-20 20 mg (Capsule (Enteric Coated)) - globe-pharmaceuticals-ltd